Dr. Ullman is retiring after 33 years of working at J&J, where he’s served in the legal sector and has been general counsel for the past decade, according to a July 18 press release.
“For three decades, Mike set the standard for Credo leadership at the company,” Johnson & Johnson CEO Joaquin Duato said in a statement. “Throughout his tenure, Mike has guided the company through an evolving global environment with respect and clarity, always keeping our patients and customers at the center of all decisions.”
With a 16-year tenure at the business, Ms. Forminard previously served as general counsel to pharmaceutical, consumer health and MedTech departments.
